What's the potential for bfly new technology given its availability

Butterfly Network, Inc. (NYSE:BFLY) has several potential growth drivers for its new technology:

1. Expansion of iQ3 Ultrasound Probe: The successful launch of the iQ3 probe has led to a 55% increase in product revenue year-over-year, indicating strong market acceptance and potential for further growth.
2. International Market Growth: Entering new markets in Indonesia, the Netherlands, and Belgium contributed to a 36% increase in international revenue, suggesting a growing global presence.
3. Formation of Octiv™: The introduction of Octiv, a subsidiary focused on extending Butterfly's proprietary chip technology, could unlock further value for shareholders and attract new investors.
4. Butterfly HomeCare Pilot: The planned launch of a virtual chronic care management pilot with a leading Medicare Advantage provider aims to improve heart failure outcomes through AI-powered imaging, indicating potential in the chronic care market.
5. Educational and Veterinary Advancements: Collaborations with Kansas City University and research supporting Butterfly's use in managing bovine respiratory disease in cattle strengthen its role in medical education and veterinary medicine.
6. Commercial Agreement with Mendaera: The partnership with Mendaera to commercialize a robotic system powered by Butterfly's Ultrasound-on-Chip™ technology represents a new revenue stream and potential for growth in the robotic intervention market.

Given these developments, Butterfly Network, Inc. is well-positioned to capitalize on its new technology and expand its market reach, driving future growth and innovation in the digital health sector.